New study questions the effectiveness of hydroxychloroquine in treating new coronavirus

U.S. President Donald Trump has previously announced at a news conference that the antimalarial drug chloroquine could treat the new coronavirus, but it is still an unproven potential treatment,media outlet TechCrunch reported. A new small-scale study by Chinese researchers shows that the antimalarial drug hydroxychloroquine is actually no more effective than standard, conventional new crown treatments.

New study questions the effectiveness of hydroxychloroquine in treating new coronavirus

The study included 30 patients who did not receive any treatment (15 in the control group) and the other half were treated with hydroxychloroquine. The study showed no statistically significant difference in the number of patients who were negative after one week. During the study, patients receiving routine treatment received antiviral drugs currently recommended for use in China, including epinavir/litonavir. A week later, 13 of the 15 control patients showed no signs of the virus, while 14 of the 15 patients treated with hydroxychloroquine showed the same results.

An earlier small study of 30 patients conducted by French researchers last week showed that the use of hydroxychloroquine alone can effectively reduce the duration and severity of COVID-19, while combining it with the antibiotic azithromycin can improve its effectiveness. The study was criticized for its methods.

Mr. Trump is clearly not a scientist or medical expert, but he has been touting the efficacy of oxychloroquine and chloroquine at white house press conferences and on Twitter, including his call for them to be used “immediately.” March 21 the drug can be no more than the doctor’s guidance, dose lethal, phoenix area couple safter with the form of the clean fish tank, chloroquine self-drug as a cause of it to ingen the information about its president they decided to accept.

Dr. Anthony Fulch, a member of the White House task force, tried to discourage anyone from reading too much of the early scientific research, but Mr. Fulch seemed disapproving of Mr. Trump and did not appear at a recent task force briefing. Most importantly, as Fuchs says, all of these potential therapies require appropriate large-scale clinical trials before they can make any clear statements about their efficacy against one or more coronaviruses. Relying on small-scale surveys means seeing differences in results, which is why you use the right controls to conduct large-scale testing to arrive at more consistent and verifiable studies.

Medical professionals around the world are working tirelessly to study all forms of treatment and conduct exact clinical trials of this kind, but they will take time to produce results – and then require conclusive research to prove that their results are repeatable and reliable. At the same time, due to the severity and life-threatening nature of the disease, treatment will continue to be treated with unproven methods, which encourages the FDA to allow case-by-case use without formal approval by sympathetic and investigative reasons. No one should consider these as a recognized solution until public health agencies have actually completed their certification of such institutions.